These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2858870)

  • 1. Lethality of opioid and antihistaminic combinations in mice.
    Poling A; Sewell RG; Gallus JA; Nearchou NI
    Pharmacol Biochem Behav; 1985 Feb; 22(2):333-5. PubMed ID: 2858870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethality of pentazocine and tripelennamine combinations in mice housed individually and in groups.
    Poling A; Kesselring J; Sewell RG; Cleary J
    Pharmacol Biochem Behav; 1983 Jan; 18(1):103-5. PubMed ID: 6828528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice.
    Sansone M; D'Udine B; Renzi P; Vetulani J
    Psychopharmacology (Berl); 1987; 93(2):155-7. PubMed ID: 2892221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of lethality in mice by combinations of pentazocine and tripelennamine.
    Waller DP; Katz NL; Morris RW
    Clin Toxicol; 1980 Mar; 16(1):17-23. PubMed ID: 7389279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supra-additive toxic interaction of nicotine with antihistamines, and enhancement by the proconvulsant pentylenetetrazole.
    Sewell RG; Nanry KP; Kennedy J; Stiger TR; Harmon RE
    Pharmacol Biochem Behav; 1985 Mar; 22(3):469-77. PubMed ID: 2859608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between H1-antagonists and opioids: a drug discrimination study.
    Suzuki T; Mori T; Tsuji M; Misawa M; Onodera K
    Psychopharmacology (Berl); 1997 Jun; 131(4):346-53. PubMed ID: 9226736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice.
    Sansone M; Castellano C; Libri V
    Psychopharmacology (Berl); 1988; 95(2):176-9. PubMed ID: 3137594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of morphine-induced hyperactivity by antihistaminic drugs in mice.
    Sansone M; Castellano C; D'Amato FR
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):239-45. PubMed ID: 2881522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of opioid analgesia by H1 and H2 antagonists.
    Bluhm R; Zsigmond EK; Winnie AP
    Life Sci; 1982 Sep 20-27; 31(12-13):1229-32. PubMed ID: 6128651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.
    Shannon HE; Su TP
    Pharmacol Biochem Behav; 1982 Oct; 17(4):789-95. PubMed ID: 6294681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity.
    Leza JC; Lizasoain I; Lorenzo P
    Gen Pharmacol; 1991; 22(2):293-6. PubMed ID: 1676005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic interactions of stimulants, narcotics and narcotic antagonists.
    Leander JD; Lucot JB
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):255-64. PubMed ID: 877411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects.
    Bhargava HN
    Clin Toxicol; 1981 Feb; 18(2):175-88. PubMed ID: 7194759
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical pharmacology of pentazocine and tripelennamine (T's and Blues).
    Lange WR; Jasinski DR
    Adv Alcohol Subst Abuse; 1986; 5(4):71-83. PubMed ID: 3751735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pentazocine and tripelennamine on analgesia.
    Cleary J; Wallace S; Grossett D; Picker M; Poling A
    Pharmacol Biochem Behav; 1983 Dec; 19(16):911-5. PubMed ID: 6657717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine.
    Oliveto AH; Slifer BL; Dykstra LA
    Pharmacol Biochem Behav; 1988 Feb; 29(2):397-401. PubMed ID: 3362933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):97-101. PubMed ID: 6541694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.